Cresset Asset Management LLC Has $1.87 Million Position in SPDR S&P Biotech ETF $XBI

Cresset Asset Management LLC boosted its holdings in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 85.9% in the third quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 18,656 shares of the exchange traded fund’s stock after buying an additional 8,618 shares during the quarter. Cresset Asset Management LLC’s holdings in SPDR S&P Biotech ETF were worth $1,869,000 at the end of the most recent reporting period.

Several other hedge funds have also added to or reduced their stakes in the business. AdvisorNet Financial Inc grew its holdings in SPDR S&P Biotech ETF by 7.3% during the 3rd quarter. AdvisorNet Financial Inc now owns 1,463 shares of the exchange traded fund’s stock worth $147,000 after acquiring an additional 100 shares during the last quarter. Sequoia Financial Advisors LLC raised its stake in shares of SPDR S&P Biotech ETF by 3.1% during the third quarter. Sequoia Financial Advisors LLC now owns 3,393 shares of the exchange traded fund’s stock valued at $340,000 after acquiring an additional 101 shares during the last quarter. Kingsview Wealth Management LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 1.8% during the third quarter. Kingsview Wealth Management LLC now owns 5,813 shares of the exchange traded fund’s stock worth $582,000 after purchasing an additional 103 shares during the period. CWC Advisors LLC. lifted its holdings in shares of SPDR S&P Biotech ETF by 2.8% during the third quarter. CWC Advisors LLC. now owns 5,707 shares of the exchange traded fund’s stock worth $572,000 after purchasing an additional 157 shares during the period. Finally, Mission Hills Financial Advisory LLC lifted its holdings in shares of SPDR S&P Biotech ETF by 0.4% during the third quarter. Mission Hills Financial Advisory LLC now owns 35,841 shares of the exchange traded fund’s stock worth $3,591,000 after purchasing an additional 157 shares during the period.

SPDR S&P Biotech ETF Stock Up 0.1%

Shares of SPDR S&P Biotech ETF stock opened at $124.00 on Monday. The stock has a market cap of $8.29 billion, a price-to-earnings ratio of 11.47 and a beta of 0.93. SPDR S&P Biotech ETF has a twelve month low of $66.66 and a twelve month high of $132.09. The company’s fifty day moving average is $125.17 and its 200 day moving average is $114.12.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.